CLOCK and breast cancer: However, the pharmacological inhibition of Cry in human breast cancer by treatment with pharmacological agent KS15 [112] inhibits the proliferation and cell viability by stimulation of Wee-1 expression [112] and stimulates the activity of heterodimer complex Bmal1:Clock [112, 113].